Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 5

FDA approve RIVAROXABAN

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 3

FDA approve IMATINIB MESYLATE

Comment Full text

SUN PHARM

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 6

FDA approve DOXORUBICIN HYDROCHLORIDE

Comment Full text

ENCUBE

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 6

FDA approve DICLOFENAC SODIUM

Comment Full text

DR REDDYS

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 4

FDA approve TRIAMCINOLONE ACETONIDE

Comment Full text

CROSSMEDIKA SA

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 6

FDA approve MOXIFLOXACIN HYDROCHLORIDE

Comment Full text

MICRO LABS

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 1

FDA approve LATANOPROST

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 3

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 5

FDA approve DEFERASIROX

Comment Full text

PADAGIS US

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 5

FDA approve SUCRALFATE

Comment Full text
  • Previous
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next

Search

News categories

  • Technical Exchange News(9055)
  • Event(407)
  • SEC News(143298)
  • FDA Approval(8415)
  • Company Report(721)
  • Business News(100345)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin